TB-500 (Thymosin Beta 4) 10-20 mg – 10 Vial Box

Description

TB-500 (TB-4) is a synthetic analogue of the naturally occurring peptide Thymosin Beta-4, investigated for its interactions with actin sequestration mechanisms and cytoskeletal regulatory pathways. It has been studied for its observed effects on fibroblast migration, angiogenic signaling, extracellular matrix reorganization, and inflammatory cytokine modulation across muscle, tendon, and ligament tissue models in experimental settings.

For Research Use Only. Not for Human Consumption.

Minimum order quantity: one box (10 vials x 10-20 mg, 100-200 mg total).

Note: Product images show branded labels for illustration purposes only. All peptides are shipped in wholesale, unbranded packaging. You can see an actual example photo of the peptide vials and container above.

Specifications

Additional information

Research

1. Malinda, Katherine M., et al. "Thymosin β4 accelerates wound healing." Journal of Investigative Dermatology 113.3 (1999): 364-368.
2. Cheng, Peng, et al. "Beneficial effects of thymosin β4 on spinal cord injury in the rat." Neuropharmacology 85 (2014): 408-416.
3. Chopp, Michael, and Zheng Gang Zhang. "Thymosin β4 as a restorative/regenerative therapy for neurological injury and neurodegenerative diseases." Expert opinion on biological therapy 15.sup1 (2015): 9-12.
4. Dubé, Karina N., and Nicola Smart. "Thymosin β4 and the vasculature: multiple roles in development, repair and protection against disease." Expert opinion on biological therapy 18.sup1 (2018): 131-139.
5. Song, Ran, et al. "Association between serum thymosin β4 levels of rheumatoid arthritis patients and disease activity and response to therapy." Clinical rheumatology 31 (2012): 1253-1258.
6. Philp, D., A. L. Goldstein, and H. K. Kleinman. "Thymosin β4 promotes angiogenesis, wound healing, and hair follicle development." Mechanisms of ageing and development 125.2 (2004): 113-115.

Testing Docs